Literature DB >> 33215578

Factors Associated with Mortality among Hospitalized Patients with COVID-19: A Retrospective Cohort Study.

Paulo Ricardo Martins-Filho1, Adriano Antunes de Souza Araújo1, Luciana Xavier Pereira2, Lucindo José Quintans-Júnior1, Waneska de Souza Barboza3, Taise Ferreira Cavalcante3, Mércia Feitosa de Souza1,4, Marco Aurélio de Oliveira Góes1,4, Victor Santana Santos2.   

Abstract

Information on the risk factors for COVID-19 mortality in low- and middle-income countries is still scarce. In this retrospective cohort study, we analyzed the factors associated with COVID-19 mortality in hospitalized patients in a poor area of Brazil. Logistic regression was used to identify factors independently associated with mortality, including gender, age, and the presence of underlying medical conditions. A total of 1,207 patients were included in the analysis, and a 1.5-fold increase in COVID-19 mortality was found among patients aged > 65 years with hypertension and diabetes (odds ratio [OR]: 1.50, 95% CI: 1.02-2.19). Moreover, infectious disease (OR: 4.31, 95% CI: 1.39-13.39), kidney disease (OR: 2.59, 95% CI: 1.27-5.27), and heart disease (OR: 2.00, 95% CI: 1.31-3.04) were also predictive for COVID-19 in-hospital death. This large cohort provides important data on potential factors associated with COVID-19 mortality in Brazil.

Entities:  

Mesh:

Year:  2021        PMID: 33215578      PMCID: PMC7790112          DOI: 10.4269/ajtmh.20-1170

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  8 in total

1.  Blood phenotype O and indirect bilirubin are associated with lower, early COVID-19-related mortality: A retrospective study.

Authors:  Alaa Efat; Sabry Shoeib; Ali ElKholy; Osama Saied Hussein Aboelela; Doaa Elshamy
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

2.  Cross-sectional study for COVID-19-related mortality predictors in a Brazilian state-wide landscape: the role of demographic factors, symptoms and comorbidities.

Authors:  Emanuele Gustani Gustani-Buss; Carlos E Buss; Luciane R Cavalli; Carolina Panis; Felipe F Tuon; Joao P Telles; Franciele A C Follador; Guilherme W Wendt; Léia C Lucio; Lirane E D Ferreto; Isabela M de Oliveira; Emerson Carraro; Lualis E David; Andréa N C Simão; Angelica B W Boldt; Maria Luiza Petzl-Erler; Wilson A Silva; David L A Figueiredo
Journal:  BMJ Open       Date:  2022-10-17       Impact factor: 3.006

3.  Predictive value of D-dimer/albumin ratio and fibrinogen/albumin ratio for in-hospital mortality in patients with COVID-19.

Authors:  Kadir Küçükceran; Mustafa Kürşat Ayranci; Abdullah Sadık Girişgin; Sedat Koçak
Journal:  Int J Clin Pract       Date:  2021-05-13       Impact factor: 3.149

4.  Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.

Authors:  Paulo Ricardo Martins-Filho; Lis Campos Ferreira; Luana Heimfarth; Adriano Antunes de Souza Araújo; Lucindo José Quintans-Júnior
Journal:  Lancet Reg Health Am       Date:  2021-08-29

5.  Adult patients admitted to a tertiary hospital for COVID-19 and risk factors associated with severity: a retrospective cohort study.

Authors:  Veridiana Baldon Dos Santos; Airton Tetelbom Stein; Sofia Louise Santin Barilli; Andresa Fontoura Garbini; Rafaela Charão de Almeida; Daniela Dos Reis Carazai; Fernanda Costa Dos Santos; Raquel Lutkmeier; Isadora Helena Greve; André Klafke; Ketlen Monteiro Mussart; Estefania Inez Wittke
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2022-02-25       Impact factor: 1.846

6.  A retrospective cohort study of 238,000 COVID-19 hospitalizations and deaths in Brazil.

Authors:  Marcos Felipe Falcão Sobral; Antonio Roazzi; Ana Iza Gomes da Penha Sobral; Brigitte Renata Bezerra de Oliveira; Gisleia Benini Duarte; Jadson Freire da Silva; Renata Maria Toscano Barreto Lyra Nogueira
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379

7.  Dynamics of hospitalizations and in-hospital deaths from COVID-19 in northeast Brazil: a retrospective analysis based on the circulation of SARS-CoV-2 variants and vaccination coverage.

Authors:  Paulo Ricardo Martins-Filho; Adriano Antunes de Souza Araújo; Lucindo José Quintans-Júnior; Bárbara Dos Santos Soares; Waneska de Souza Barboza; Taise Ferreira Cavalcante; Victor Santana Santos
Journal:  Epidemiol Health       Date:  2022-04-05

8.  Factors associated with mortality in hospitalized cardiovascular disease patients infected with COVID-19.

Authors:  Roohallah Alizadehsani; Rahimeh Eskandarian; Mohaddeseh Behjati; Mehrdad Zahmatkesh; Mohamad Roshanzamir; Navid H Izadi; Afshin Shoeibi; Azadeh Haddadi; Fahime Khozeimeh; Fariba A Sani; Zahra A Sani; Zahra Roshanzamir; Abbas Khosravi; Saeid Nahavandi; Nizal Sarrafzadegan; Sheikh Mohammed Shariful Islam
Journal:  Immun Inflamm Dis       Date:  2022-01-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.